Senior insider sale
Head of Research & Technology at SANGAMO THERAPEUTICS, INC — senior position signals high conviction
$17.7K
69.83K shares
What this filing means
DAVIS GREGORY D plans to sell 69.83K shares of SANGAMO THERAPEUTICS, INC valued at approximately $17.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/22/2026ACC: 0001950047-26-003686
Officer· Head of Research & Technology
Since Feb 2026
69.83K
Shares to sell
$17.7K
Approx. market value
69.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
6/25/2021
69.83KTotal acquired69.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2021 | Restricted Stock Not Applicable | 69.83K | — |
| Total | 69.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
69.83K
Market value
$17.7K
4/22/2026
Total
Units
69.83K
Value
$17.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/22/2026 | 69.83K | $17.7K | NASDAQ | Planned |
| Total | 69.83K | $17.7K | ||